1
|
Hak AE, de Paepe B, de Bleecker JL, Tak PP
and de Visser M: Dermatomyositis and polymyositis: new treatment
targets on the horizon. Neth J Med. 69:410–421. 2011.PubMed/NCBI
|
2
|
Buchbinder R and Hill CL: Malignancy in
patients with inflammatory myopathy. Curr Rheumatol Rep. 4:415–426.
2002. View Article : Google Scholar : PubMed/NCBI
|
3
|
Savage KJ, Chhanabhai M, Gascoyne RD and
Connors JM: Characterization of peripheral T-cell lymphomas in a
single North American institution by the WHO classification. Ann
Oncol. 15:1467–1475. 2004. View Article : Google Scholar : PubMed/NCBI
|
4
|
Sargent JT and Smith OP: Haematological
emergencies managing hypercalcaemia in adults and children with
haematological disorders. Br J Haematol. 149:465–477. 2010.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Shepard MM and Smith JW III:
Hypercalcemia. Am J Med Sci. 334:381–385. 2007. View Article : Google Scholar : PubMed/NCBI
|
6
|
Dyck PJ, Boes CJ, Mulder D, Millikan C,
Windebank AJ, Dyck PJ and Espinosa R: History of standard scoring,
notation, and summation of neuromuscular signs. A current survey
and recommendation. J Peripher Nerv Syst. 10:158–173. 2005.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Lister TA, Crowther D, Sutcliffe SB, et
al: Report of a committee convened to discuss the evaluation and
staging of patients with Hodgkin’s disease: Cotswolds meeting. J
Clin Oncol. 7:1630–1636. 1989.PubMed/NCBI
|
8
|
Hill CL, Zhang Y, Sigurgeirsson B, et al:
Frequency of specific cancer types in dermatomyositis and
polymyositis: a population-based study. Lancet. 357:96–100. 2001.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Aggarwal R and Oddis CV: Paraneoplastic
myalgias and myositis. Rheum Dis Clin North Am. 37:607–621. 2011.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Chen YJ, Wu CY, Huang YL, Wang CB, Shen JL
and Chang YT: Cancer risks of dermatomyositis and polymyositis: a
nationwide cohort study in Taiwan. Arthritis Res Ther. 12:R702010.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Selva-O’Callaghan A, Grau JM,
Gámez-Cenzano C, et al: Conventional cancer screening versus PET/CT
in dermatomyositis/polymyositis. Am J Med. 123:558–562. 2010.
View Article : Google Scholar
|
12
|
Endres DB: Investigation of hypercalcemia.
Clin Biochem. 45:954–963. 2012. View Article : Google Scholar : PubMed/NCBI
|
13
|
Vassilopoulou-Sellin R, Newman BM, Taylor
SH and Guinee VF: Incidence of hypercalcemia in patients with
malignancy referred to a comprehensive cancer center. Cancer.
71:1309–1312. 1993. View Article : Google Scholar : PubMed/NCBI
|
14
|
Clines GA and Guise TA: Hypercalcaemia of
malignancy and basic research on mechanisms responsible for
osteolytic and osteoblastic metastasis to bone. Endocr Relat
Cancer. 12:549–583. 2005. View Article : Google Scholar : PubMed/NCBI
|
15
|
Majumdar G: Incidence and prognostic
significance of hypercalcaemia in B-cell non-Hodgkin’s lymphoma. J
Clin Pathol. 55:637–638. 2002. View Article : Google Scholar : PubMed/NCBI
|
16
|
Hewison M, Kantorovich V, Liker HR, et al:
Vitamin D-mediated hypercalcemia in lymphoma: evidence for hormone
production by tumor-adjacent macrophages. J Bone Miner Res.
18:579–582. 2003. View Article : Google Scholar : PubMed/NCBI
|
17
|
No authors listed. A predictive model for
aggressive non-Hodgkin’s lymphoma. The International Non-Hodgkin’s
Lymphoma Prognostic Factors Project. N Engl J Med. 329:987–994.
1993. View Article : Google Scholar
|
18
|
Koh LK: The diagnosis and management of
hypercalcaemia. Ann Acad Med Singapore. 32:129–139. 2003.PubMed/NCBI
|